Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 76.26 USD 2.64%
Market Cap: 29.9B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+38%
Revenue
Forecast
+16%
Operating Income
Forecast
+34%
Net Income
Forecast
+29%

Wall Street
Price Targets

DXCM Price Targets Summary
Dexcom Inc

Wall Street analysts forecast DXCM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DXCM is 105.4 USD with a low forecast of 85.07 USD and a high forecast of 126 USD.

DXCM Lowest Forecast
Wall Street Target
85.07 USD
12% Upside
DXCM Average Forecast
Wall Street Target
105.4 USD
38% Upside
DXCM Highest Forecast
Wall Street Target
126 USD
65% Upside
Lowest
Price Target
85.07 USD
12% Upside
Average
Price Target
105.4 USD
38% Upside
Highest
Price Target
126 USD
65% Upside
Dexcom Inc Competitors:
Price Targets
2160
Microport Cardioflow Medtech Corp
10% Upside
IBAB
Ion Beam Applications SA
35% Upside
KRMD
Repro Med Systems Inc
39% Upside
BIM
Biomerieux SA
10% Upside
2160
Microport Cardioflow Medtech Corp
10% Upside
IBAB
Ion Beam Applications SA
35% Upside
KRMD
Repro Med Systems Inc
39% Upside
BIM
Biomerieux SA
10% Upside
GKOS
Glaukos Corp
35% Upside
I
099190
I Sens Inc
49% Upside
MOVE
Medacta Group SA
11% Upside
BSX
Boston Scientific Corp
19% Upside

Revenue
Forecast

Revenue Estimate
Dexcom Inc

For the last 13 years the compound annual growth rate for Dexcom Inc's revenue is 36%. The projected CAGR for the next 3 years is 16%.

36%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Dexcom Inc

The compound annual growth rate of Dexcom Inc's operating income for the next 3 years is 34%.

N/A
Past Growth
34%
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Dexcom Inc

The compound annual growth rate of Dexcom Inc's net income for the next 3 years is 29%.

N/A
Past Growth
29%
Estimated Growth
Estimates Accuracy
-20%
Average Miss
What are analyst estimates?

See Also

Summary
DXCM intrinsic value, competitors valuation, and company profile.
DCF Valuation
DXCM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DXCM stock valuation using valuation multiples.
Wall Street Estimates
DXCM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DXCM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DXCM's stock price target?
Price Target
105.4 USD

According to Wall Street analysts, the average 1-year price target for DXCM is 105.4 USD with a low forecast of 85.07 USD and a high forecast of 126 USD.

What is Dexcom Inc's Revenue forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for Dexcom Inc's revenue is 36%. The projected CAGR for the next 3 years is 16%.

What is Dexcom Inc's Operating Income forecast?
Projected CAGR
34%

The compound annual growth rate of Dexcom Inc's operating income for the next 3 years is 34%.

What is Dexcom Inc's Net Income forecast?
Projected CAGR
29%

The compound annual growth rate of Dexcom Inc's net income for the next 3 years is 29%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 279,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.